CLINICAL_TRIALS
trial_result
· 2014-06-13
Clinical Trial Update: BI 10773 add-on to Metformin in Patients With Type 2 Diabetes [Phase 2]
Summary
A Phase 2 trial evaluating BI-10773 as add-on therapy to metformin in Type 2 diabetes has completed, and its results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-06-13